Unlock stock picks and a broker-level newsfeed that powers Wall Street.
48.20
+1.32
+(2.82%)
At close: 4:00:00 PM EDT
47.49
-0.71
(-1.47%)
After hours: 5:21:55 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 0.11 | -0.53 | -1.23 | -1.07 |
| Low Estimate | -0.58 | -0.75 | -2.42 | -3.53 |
| High Estimate | 1.87 | -0.05 | 0.16 | 2.95 |
| Year Ago EPS | 3.26 | -0.5 | 4.23 | -1.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | 30.44M | 6.56M | 98.78M | 141.31M |
| Low Estimate | -- | -- | 16M | -- |
| High Estimate | 165M | 25M | 225M | 449M |
| Year Ago Sales | 254.95M | 4.17M | 434.43M | 98.78M |
| Sales Growth (year/est) | -88.06% | 57.32% | -77.26% | 43.06% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.6 | -0.41 | -0.53 | 0.25 |
| EPS Actual | 3.26 | -0.5 | -0.54 | 1.98 |
| Difference | 1.66 | -0.09 | -0.01 | 1.73 |
| Surprise % | 103.79% | -21.11% | -1.89% | 692.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.11 | -0.53 | -1.23 | -1.07 |
| 7 Days Ago | 0.11 | -0.53 | -1.23 | -1.07 |
| 30 Days Ago | 0.68 | -0.53 | -0.84 | -0.98 |
| 60 Days Ago | 0.7 | -0.53 | -0.8 | -0.94 |
| 90 Days Ago | 0.25 | -0.54 | -1.23 | -0.95 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 1 | -- | 3 | 5 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PTGX | -96.63% | -6.25% | -128.99% | 13.05% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Wedbush: Outperform to Outperform | 3/28/2025 |
| Maintains | Truist Securities: Buy to Buy | 3/11/2025 |
| Reiterates | BMO Capital: Outperform to Outperform | 3/11/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/10/2025 |
Related Tickers
MLYS Mineralys Therapeutics, Inc.
14.00
+1.16%
AKRO Akero Therapeutics, Inc.
41.95
+8.57%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
CYTK Cytokinetics, Incorporated
40.25
+7.33%
MRUS Merus N.V.
43.01
+8.61%
IDYA IDEAYA Biosciences, Inc.
16.35
+10.70%
SRRK Scholar Rock Holding Corporation
32.54
+8.25%
MLTX MoonLake Immunotherapeutics
38.05
+4.68%
CGEM Cullinan Therapeutics, Inc.
7.82
+4.27%
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%